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E-mail address: andreas.klatt@uk-koeln.de (A.R. KlHere, we tested the matrilin-3-dependent induction of osteoarthritis-associated genes in primary
human chondrocytes. Matrilin stimulation leads to the induction of MMP1, MMP3, MMP13,
COX-2, iNOS, IL-1b, TNFa, IL-6 and IL-8. Furthermore, we show the participation of ADAMTS4 and
ADAMTS5 in the in vitro degradation of matrilin-3. We provide evidence for a matrilin-3-dependent
feed-forward mechanism of matrix degradation, whereby proteolytically-released matrilin-3
induces pro-inﬂammatory cytokines as well as ADAMTS4 and -5 indirectly via IL-1b. ADAMTS4
and ADAMTS5, in turn, cleave matrilin-3 and may release more matrilin-3 from the matrix, which
could lead to further release of pro-inﬂammatory cytokines and proteases in cartilage.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Osteoarthritis (OA), one of the most common joint diseases with
unknown etiology, is characterized by the progressive degenera-
tion of articular cartilage. Proteolytic enzymes such as MMPs (ma-
trix-metalloproteinases) and ADAMTSs (a disintegrin and MMP
with thrombospondin motifs) substantially participate in the deg-
radation of collagen II and aggrecan. In the meantime, many prote-
olytic enzymes have been shown to be induced by pro-
inﬂammatory cytokines [1]. This important role of IL-1b and TNFa
in cartilage disorders has been revealed in in vitro and in vivo stud-
ies [2,3]. IL-1b and TNFa activate a multitude of intracellular sig-chemical Societies. Published by E
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att).naling pathways, among which the NFjB and the mitogen-
activated protein kinase (MAPK) pathways, i.e. the c-Jun NH2-ter-
minal (JNK), p38, and the extracellular signal-regulated kinase
(ERK) pathways, predominate in chondrocytes. Several studies
established gene induction of MMPs and pro-inﬂammatory cyto-
kines by matrix proteins such as ﬁbronectin [4] or collagen II [5].
This gene induction is associated with the activation of the MAPK
and NFkB signaling pathways [6]. Thus, components of the carti-
lage matrix not only fulﬁll structural and mechanical tasks but
also, similar to pro-inﬂammatory cytokines, have the potential to
modulate the cartilage phenotype and to contribute to progressive
cartilage degradation.
In the cartilage matrix collagen II occurs in composite ﬁbrils to-
gether with collagens XI and IX [7,8]. The surface of these is cov-
ered by a set of proteins and proteoglycans that bind either
directly to collagen II or to collagen IX [9]. It may be assumed that
these periﬁbrillar proteins must be removed before MMPs can at-
tack the actual collagens in the ﬁbril structure. Prominent mem-
bers of this group are the matrilins, a family of four modular,
multisubunit matrix proteins, which are expressed in cartilagelsevier B.V. All rights reserved.
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the matrilins serve as adaptor proteins and mediate interactions
between collagen-containing ﬁbrils and other extracellular matrix
structures. Matrilin-3 expression is increased in OA [11] and differ-
ent mutations in the human MATN3 gene have been linked to the
development of hand OA [12], intervertebral disc degeneration and
multiple epiphyseal dysplasia [13], a chondrodysplasia exhibiting
OA as one of its symptoms. This association of matrilin-3 with
degenerative joint disease makes it a candidate for a role as matrix
protein signal causing chondrocyte activation.
In the present study, we examined the potential of matrilin-3 to
modulate the gene expression proﬁle of primary human chondro-
cytes (PHCs). We did so by testing the matrilin-3-dependent induc-
tion of pro-inﬂammatory cytokines such as TNFa, IL-1b, IL-6, and
IL-8, of inducible nitric oxide synthetase (iNOS) and cyclooxygen-
ase-2 (COX-2), of MMP1, -3 and -13, as well as of matrilin-3 itself
in PHCs.Table 1
Primers used for semi-quantitative PCR.
Primer Sequence
COX-2 (fwd) 50-GTG CCT GAT GAT TGC CCG ACT CC-30
COX-2 (rve) 50-GCC CCA CAG CAA ACC GTA GAT G-30
GAPDH (fwd) 50-GAA GGT GAA GGT CGG AGT C-30
GAPDH (rve) 50-GAA GAT GGT GAT GGG ATT TC-30
IL-6 (fwd) 50-GTT GTT TTC TGC CAG TGC CTC TTT-30
IL-6 (rve) 50-CCT TCG GTC CAG TTG CCT TCT-30
iNOS (fwd) 50-TCG GCA GAA TCT ACA AAG TCC-30
iNOS (rve) 50-TGG CCA TCC TCA CAG GAG-30
MATN3 (fwd) 50-CTC GGG CCC AAG CAT CTG-30
MATN3 (rve) 50-TGT CGG CAT TCA AGG TGT ATC C-30
MMP1 (fwd) 50-ATT CTA CTG ATA TCG GGG CTT TGA-30
MMP1 (rve) 50-ATG TCC TTG GGG TAT CCG TGT AG-30
MMP3 (fwd) 50-ATG CCC ACT TTG ATG ATG ATG AAC-30
MMP3 (rve) 50-CCA CGC CTG AAG GAA GAG ATG-30
MMP13 (fwd) 50-GCT GCC TTC CTC TTC TTG AG-30
MMP13 (rve) 50-TGC TGC ATT CTC CTT CAG GA-302. Experimental
2.1. Expression and puriﬁcation of recombinant matrilin-3
The production of the expression vectors for N-terminally His6-
tagged or C-terminally StrepII-tagged murine matrilin-3 is de-
scribed elsewhere [14]. Each of the expression constructs was
transfected into 293EBNA cells with LipofectamineTM2000 (Invitro-
gen) according to the manufacturer’s instructions. The cell lines
were selected with puromycin (1 lg/ml) and cultured under ser-
um-free conditions prior to harvest of conditioned cell culture
supernatants. His6-tagged matrilin-3 was puriﬁed from condi-
tioned supernatants using TALON Metal Afﬁnity Resin (Clontech),
StrepII-tagged matrilin-3 was afﬁnity puriﬁed from conditioned
supernatants using Streptactin-Sepharose Afﬁnity Resin (IBA).
2.2. Overexpression of ADAMTS4 and ADAMTS5
cDNAs encoding human full-length ADAMTS4 and ADAMTS5
(Invitek GmbH) were cloned into the expression vector pCEP4
(Invitrogen). Each of the expression constructs was transfected into
293EBNA cells expressing recombinant matrilin-3 with Lipofect-
amineTM2000 (Invitrogen). The cell lines were selected with hygro-
mycin (200 lg/ml) and cultured under serum-free conditions
prior to harvest of conditioned cell culture supernatants.
2.3. Isolation, cultures and stimulation of PHCs
Articular cartilage taken from femoral condyles and tibial pla-
teaus of human knee joints was obtained from patients suffering
from osteoarthritis at the time of total joint replacement surgery.
Chondrocytes were taken from whole condyles. To isolate PHCs,
cartilage samples were rinsed with DMEM/F12 medium (Gibco),
minced, and digested with Pronase (0.4%, 90 min, Calbiochem)
and Collagenase-P (0.025%, 16 h, Roche) in DMEM/F12 medium
containing 5% FCS Gold (PAA). PHCs were ﬁltered with a 100 lm
and a 40 lm ﬁlter, seeded (1  106 cells/well) in 6-well multiwell
plates (Falcon) in DMEM/F12 (PAN) containing 10% BD-NU serum
(BD Biosciences) and 50 lg/ml gentamicin (Gibco) and then culti-
vated in a CO2 incubator (5% CO2, 37 C).
Cells were incubated in the absence or in the presence of matri-
lin-3 at different concentrations and for different time-periods (see
ﬁgures). For this purpose, matrilin-3 was dialyzed against culture
medium. The dialysis buffer (devoid of matrilin-3) was used as a
negative control. Alternatively, incubations were performed in
the presence of 50 lg/ml acetic acid–soluble collagen II from chick-
en sternal cartilage (Sigma) dissolved in 0.25% acetic acid, 20 lg/mlcollagen I from rat tail (collagen R, Serva), or 10 ng/ml IL-1b
(Roche)/10 lg/ml LPS (lipopolysaccharide, Sigma). As negative
control for collagen II, PHCs were incubated in the absence of col-
lagen II, but with the relevant amount of acetic acid. As negative
controls for collagen I and IL-1b/LPS, cells were incubated with cul-
ture medium. Expression values (fold-induction) were related to
the values of the negative controls.
To further demonstrate the speciﬁcity of stimulation, culture
medium was depleted for matrilin-3 by incubation with TALON
matrix prior to stimulation.
2.4. Quantitative real-time RT-PCR
Real-time RT-PCR was used to detect mRNAs encoding MMP1,
MMP3, MMP13, iNOS, COX-2, IL-6, and matrilin-3. First strand
cDNA was prepared and reversely transcribed into cDNA using
SuperScript III Reverse Transcriptase (Invitrogen) according to the
manufacturer’s protocol. Quantitative real-time RT-PCR was per-
formed using LightCycler DNA Master SyBrGreen I Kit (Roche),
the LightCycler device and software (Roche). Expression values
were compared to a gene speciﬁc cDNA standard curve and normal-
ized to GAPDH expression. Primer sequences are listed in Table 1.
2.5. SDS–PAGE
Cell culture supernatants were separated on a 4–12% Bis–Tris
gel (Invitrogen) before transferring the proteins to a PVDF mem-
brane (0.45 lm) (Invitrogen). Membranes were blocked with 5%
milk powder, incubated in an appropriate dilution of an afﬁnity-
puriﬁed polyclonal rabbit anti-matrilin-3 antiserum [15], and
ﬁnally incubated in a 1/5000 dilution of horseradish peroxidase-
conjugated polyclonal donkey anti-rabbit IgG antiserum (Amer-
sham Pharmacia Biotech). Membranes were treated with ECL Plus
according to the manufacturer’s instructions (Amersham Pharma-
cia Biotech), and visualized on Hyperﬁlm (Amersham Bioscience).
2.6. ELISA
Release of TNFa, IL-1b, IL-6, and IL-8 was determined in cell
culture supernatants using commercial ELISA kits in accordance
with the manufacturer’s protocol. For the detection of TNFa and
IL-1b the BD OptEIA Human TNF ELISA and IL-1b Kit II (BD Biosci-
ences) were used and for the detection of IL-6 and IL-8 the human
IL-6 and IL-8 ELISA kits (BD Bioscience).
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To test for associations between incubation time and biological
effects, Pearson correlation analysiswas used. To test for differences
between effects, ANOVA was used. P-values of less than 0.05 indi-
cate signiﬁcant results, P-values of less than 0.01 indicate highly sig-
niﬁcant results. Abbreviations used: P = P-value at the 0.05 level of
signiﬁcance, n, number, df = degree of freedom, F = test statistic AN-
OVA, r = correlation coefﬁcient Pearson correlation analysis.
3. Results
3.1. Dose- and time-dependent induction of IL-6 release by matrilin-3
To determine whether matrilin-3 can induce the pro-inﬂam-
matory cytokine IL-6 PHCs were stimulated with matrilin-3 atFig. 1. Speciﬁc, dose- and time-dependent induction of IL-6 by matrilin-3. (A and B) PHC
(5 lg/ml, 25 lg/ml, 50 lg/ml). Cell culture supernatants were harvested and IL-6 levels
expression/release relative to base expression/release (CTL). Matrilin-3 induces IL-6 in
correlation between incubation time and IL-6 induction at different concentrations. (C) PH
or matrilin-3-depleted culture-medium (M3+T) (see Sections 2 and 3). Cell supernatants w
release, i.e., release relative to base release (CTL). CM, pure culture medium. CTL = DP = d
differences between induced and control values or correlations, respectively).different concentrations (0, 5, 25 or 50 lg/ml) (Fig. 1A and B).
Both recombinant His6- and StrepII-tagged matrilin-3 was used
in the stimulation of PHCs and gave a comparably strong induc-
tion of IL-6 (results not shown). To prevent dilution of the med-
ium by the addition of matrilin-3, afﬁnity-puriﬁed matrilin-3
was dialyzed against cell culture medium. The last dialysis buffer
was used as a negative control. Further negative controls were
obtained by incubating PHCs with pure culture medium or with
medium containing collagen I, which is known not to induce IL-
6 [5]. Cell culture supernatants were analyzed by ELISA for the
presence of IL-6 and a dose-dependent increase in IL-6 release
was observed (P < 0.01, n = 12, df1 = 3, df2 = 8, F = 22.1, ANOVA;
Fig. 1A). Moreover, PHCs were stimulated for 3 h, 6 h, or 24 h,
respectively, with matrilin-3 at different concentrations (0, 5, 25
or 50 lg/ml). The resulting IL-6 release was determined as de-
scribed above and was found to be induced in a time-dependents were stimulated for 3, 6 or 24 h with matrilin-3 (M3) in different concentrations
determined by ELISA. All results are presented as relative expression/release, i.e.,
a dose- and time-dependent manner (A). B additionally illustrates the positive
Cs were incubated for 24 h with 50 lg/ml matrilin-3 (M3), 20 lg/ml collagen I (C1),
ere harvested and IL-6 levels determined by ELISA. Results are presented as relative
ialysis buffer. Error bars represent the S.D. ** indicates highly signiﬁcant results (i.e.
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OVA, Fig. 1A).Fig. 2. Depletion of matrilin-3 in culture medium. Matrilin-3-containing culture
medium, incubated either without () or with (+) TALON matrix and subsequently
centrifuged, was subjected to SDS–PAGE and stained with silver nitrate. Incubation
of culture medium with TALON-matrix leads to almost complete matrilin-3
depletion.
Fig. 3. Effects of matrilin-3 and collagen II on the expression of TNFa, IL-1, IL-6, and IL-8 p
acetic acid–soluble collagen II (C2) dissolved in 0.25% acetic acid, or IL1-b [10 ng/ml]/LPS
TNFa levels determined by ELISA. All results are presented as relative expression/release,
induces IL-6, TNFa, IL-1b and IL-8. Stimulation with collagen II leads to induction of IL-6, I
**/* indicates highly signiﬁcant/signiﬁcant differences between induced and control valuTo further demonstrate the speciﬁcity of the IL-6 stimulation,
culture medium containing His6-tagged matrilin-3 was incubated
with TALON matrix and centrifuged prior to stimulation. TALON
binds the recombinant His6-tagged matrilin-3 and by this depletes
the culture medium of the protein. The efﬁcient depletion was con-
ﬁrmed by SDS–PAGE (Fig. 2). As expected, matrilin-3-depletion re-
sulted in a reduction of IL-6 release to control levels (P < 0.01,
n = 12, df1 = 3, df2 = 8, F = 10.0, ANOVA, Fig. 1C). In conclusion, we
could demonstrate that IL-6 is speciﬁcally induced by matrilin-3
in a time- and dose-dependent manner.
3.2. Induction of TNFa, IL-1b, IL-6 and IL-8 release by matrilin-3 and
collagen II
Recently, we could show that IL-6 release can be induced also
by collagen II, but not by collagen I [5]. Hence, we examined the
induction of release of further pro-inﬂammatory cytokines associ-
ated with OA by matrilin-3 or collagen II, respectively. For this pur-
pose PHCs were incubated with matrilin-3 or collagen II for 6 h or
24 h, respectively. The supernatants were analyzed for the pres-
ence of IL-6, IL-8, TNFa and IL-1b (Fig. 3). Both matrilin-3 and col-
lagen II stimulated the release of IL-6, IL-8, and IL-1b in a time-
dependent fashion (matrilin-3: IL-6 (P < 0.01, F = 22.0), IL-8
(P < 0.01, F = 30.2), IL-1b (P = 0.06, F = 3.4); collagen II: IL-6
(P < 0.01, F = 10.6), IL-8 (P < 0.01, F = 16.1), IL-1b (P < 0.05,
F = 5.3); n = 20, df1 = 2, df2 = 17, ANOVA). Furthermore, matrilin-3
stimulation led to strong release of TNFa (P < 0.01, F = 6.3, n = 20,
df1 = 2, df2 = 17, ANOVA). Collagen II stimulation induced onlyrotein. PHCs were stimulated for 6 or 24 h with 50 lg/ml matrilin-3 (M3), 50 lg/ml
[10 lg/ml] (IL1). Cell culture supernatants were harvested and IL-6, IL-8, IL-1b, and
i.e., expression/release relative to base expression/release (CTL). Matrilin-3 strongly
L-1b, and IL-8, but only weak TNFa release. Error bars represent the S.D. of the mean.
es.
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VA). Taken together the results show that while both matrilin-3
and collagen II induce the release of pro-inﬂammatory cytokines,
they seem to differ in their gene induction potential.
Furthermore, we stimulated PHCs with a mixture of IL-1b and
LPS. Stimulation of this kind generally leads to massive gene induc-
tion. Even though IL-1b/LPS gave a stronger induction than matri-
lin-3, the effects were of a similar magnitude. Clearly, matrilin-3
exerts catabolic effects on cartilage similar to those of IL-1b.
3.3. Gene induction of MMP1, MMP3, MMP13, matrilin-3, IL-6, COX
and iNOS by matrilin-3 and collagen II
We investigated the potential of matrilin-3 to induce the
expression of MMP1, MMP3, MMP13, iNOS, COX-2, IL-6 and matri-
lin-3 mRNA in PHCs. PHCs were stimulated for 6 or 24 h with
50 lg/ml matrilin-3. Furthermore, we stimulated PHCs with colla-
gen II or a mixture of IL-1b and LPS. PHCs were incubated with
matrilin-3 dialysis buffer or, alternatively, culture medium as con-
trols. Cells were collected and gene expression was analyzed by
semi-quantitative RT-PCR (Fig. 4). This treatment with matrilin-3
or collagen II resulted in a signiﬁcant induction of MMP1, MMP3,
MMP13, COX-2, iNOS, and IL-6 mRNA which in each case could
be shown to be time-dependent except for the induction of COX-
2 and iNOS by matrilin-3 (matrilin-3: MMP1 (P < 0.01, F = 12.2),
MMP3 (P < 0.01, F = 40.4), MMP13 (P < 0.01, F = 23.3), COX-2
(P < 0.05, F = 5.7), iNOS (P < 0.01, F = 13.3), IL-6 (P < 0.01, F = 10.2);
collagen II: MMP1 (P < 0.01, F = 11.0), MMP3 (P < 0.01, F = 6.6),
MMP13 (P < 0.01, F = 17.5), COX-2 (P < 0.01, F = 6.1), iNOS
(P < 0.01, F = 9.3), IL-6 (P < 0.01, F = 8.7); n = 20, df1 = 2, df2 = 17,Fig. 4. Effects of matrilin-3 and collagen II on the mRNA expression levels for MMP1, M
matrilin-3 (M3). Alternatively, PHCs were incubated with 50 lg/ml acetic acid-soluble co
mRNA was determined by quantitative RT-PCR. Results are normalized to GAPDH and
Matrilin-3 and collagen II each induce MMP1, MMP3, MMP13, iNOS, and COX-2 mRNA
F = 23.3), iNOS (P < 0.01, F = 13.3), COX-2 (P < 0.05, F = 5.7); collagen II: MMP1 (P < 0.01, F
COX-2 (P < 0.01, F = 6.1); n = 20, df1 = 2, df2 = 17, ANOVA). Error bars represent the S.D. o
and control values.ANOVA). We could not ﬁnd any clear dependence of matrilin-3
mRNA levels on the addition of the proteins (matrilin-3: P = 0.23,
F = 1.6; collagen II: P = 0.70, F = 0.4; n = 20, df1 = 2, df2 = 17,
ANOVA).
The stimulation of PHCs with matrilin-3 results in strong re-
lease of IL-6, IL-8, TNFa, and IL-1b. These cytokines, in turn, have
the potential to inﬂuence gene induction in PHCs. We cannot rule
out the possibility that cytokines that are primarily induced by
matrilin-3 contribute to the induction of the examined genes.
However, the early increase in the respective mRNAs points to an
immediate gene induction by matrilin-3.
3.4. Overexpression of ADAMTS4 and ADAMTS5 inﬂuences matrilin-3
processing in cell culture
Matrilin-3 is an integral component of the ECM, however, we
hypothesize that it has the ability to differentially modulate chon-
drocyte gene expression. Recently, it was reported that matrilin-4
is proteolytically processed by ADAMTS4 and ADAMTS5 [16]. The
potential cleavage site is conserved in all matrilins, also in matri-
lin-3 [16]. If matrilin-3 is processed in a similar manner, this could
be a mechanism by which matrilin-3 is released from the matrix
and presented to the chondrocytes in OA. We therefore studied
the matrilin-3 processing by ADAMTS4 and ADAMTS5 by transfec-
tion of matrilin-3 expressing 293EBNA cells with cDNAs coding for
the full-length ADAMTS4 and ADAMTS5 proteases. Cells transfec-
ted with empty vector DNA were used as controls. Supernatants
were analyzed by SDS–PAGE and immunoblot using a polyclonal
matrilin-3 antibody (Fig. 5). Transfection of matrilin-3 over-
expressing cells with ADAMTS4 or ADAMTS5 resulted in anMP3, MMP13, iNOS, and COX-2. PHCs were stimulated for 6 or 24 h with 50 lg/ml
llagen II (C2) dissolved in 0.25% acetic acid, or IL1-a [10 ng/ml]/LPS [10 lg/ml] (IL1).
presented as relative expression, i.e., expression relative to base expression (CTL).
(matrilin-3: MMP1 (P < 0.01, F = 12.2), MMP3 (P < 0.01, F = 40.4), MMP13 (P < 0.01,
= 11.0), MMP3 (P < 0.01, F = 6.6), MMP13 (P < 0.01, F = 17.5), iNOS (P < 0.01, F = 9.3);
f the mean. **/* indicates highly signiﬁcant/signiﬁcant differences between induced
Fig. 5. Overexpression of ADAMTS4 and ADAMTS5 in matrilin-3 expressing 293EBNA cells. Full length ADAMTS4 and ADAMTS5 were co-expressed with matrilin-3 in
293EBNA cells. Cell supernatants were subjected to SDS–PAGE on 4–12% gels. After transfer to nitrocellulose, matrilin-3 was detected with matrilin-3 speciﬁc antibodies. The
experiments show the participation of ADAMTS4 and ADAMTS5 in the degradation of matrilin-3 in vitro. q: tetramer, t: trimer, d: dimer, m: monomer, cc: coiled-coil domain.
3616 A.R. Klatt et al. / FEBS Letters 583 (2009) 3611–3617increased proportion of processed matrilin-3 fragments. These
experiments clearly show that matrilin-3 is a substrate of ADAM-
TS4 and ADAMTS5 and indicate the participation of ADAMTS4
and ADAMTS5 in the in vivo degradation of matrilin-3.
4. Discussion
We investigated the role of matrilin-3 as a regulator of matrix
degradation in human cartilage and could demonstrate a strong
matrilin-3-dependent induction of the pro-inﬂammatory cytokines
TNFa, IL-1b, IL-6, and IL-8, which have been shown to be up-regu-
lated in OA [1,17,18]. These pro-inﬂammatory cytokines enhance
the inﬂammatory process and induce various matrix degrading en-
zymes and are thus important regulators of cartilage degradation.
In addition, we found a strong induction of iNOS and COX-2 by
matrilin-3, both genes being involved in OA pathogenesis in carti-
lage [19–21]. Furthermore, we could show that matrilin-3 induces
the expression of MMP1, MMP3, and MMP13 in PHCs, which indi-
cates that matrilin-3 mediates and modulates ECM degradation.
In a previous study, we found that cytokines, such as IL6, can
be induced in PHCs by collagen II [5,6]. Chondrocytes respond to
IL-6 by producing pro-inﬂammatory cytokines and proteolytic
enzymes, which results in collagen II degradation. Collagen II
fragments, in turn, can induce pro-inﬂammatory cytokines and
MMPs, which then leads to further acceleration and perpetuation
of cartilage matrix degradation. We now show that matrilin-3
may contribute to this matrix-speciﬁc feed-forward mechanism
of cartilage degradation in OA in a comparable manner: Proteo-
lytically released matrilin-3 induces pro-inﬂammatory cytokines
as well as ADAMTS4 and -5 indirectly via IL-1b [22,23]. ADAM-
TS4 and ADAMTS5 cleave matrilin-3 and may release more
matrilin-3 from the matrix which could in turn lead to further
induction of pro-inﬂammatory cytokines and proteases in PHCs.
The effects of matrilin-3 are almost as strong as those of IL-1b
combined with LPS. We suppose that apart from systemic pro-
inﬂammatory cytokines proteolytically released matrix compo-nents decisively contribute to ECM degradation in the course
of OA.
The PHCs we used in our study originate from osteoarthritic hu-
man knee joints. Chondrocytes were taken from whole condyles as
opposed to isolated unaffected or OA-affected regions. Hence, our
PHCs represent a mixture of chondrocytes from OA-affected and
unaffected regions. We can therefore not discriminate between
OA-affected and unaffected chondrocytes with regard to their re-
sponse to matrilin-3 stimulation. The expression of the corre-
sponding receptor may be critical. Only PHCs expressing the
appropriate receptor will be susceptible to matrilin-3 stimulation.
The identiﬁcation of this receptor and the determination of its
expression pattern in normal and OA-affected chondrocytes as well
as in different cartilage zones will be an important goal for future
research.
Because of the multifactorial pathogenesis of OA and because
of the lack of appropriate biochemical markers for the early diag-
nosis of OA it is important to examine the pathomechanisms that
after initiation lead to the maintenance and progression of OA.
Notably, research should focus on the elucidation of further carti-
lage speciﬁc mediators and speciﬁc receptors and signal transduc-
tion cascades. These signaling pathways should be compared to
the signal transduction cascades of pro-inﬂammatory cytokines.
Ultimately, pharmacological targets could be identiﬁed that
reduce the effects of both cytokines and ECM components and
thus retard the progression of cartilage degradation. Furthermore,
it seems probable that similar cartilage signaling processes play
an important role in matrix remodeling during enchondral osteo-
genesis. Further investigations of these mechanisms would
provide a better understanding of cartilage degradation and bone
formation.
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